Related Experiment Video
Updated: Oct 4, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and
R E Polonio1, L A Mermel, G E Paquette
1Department of Biochemistry, Microbiology and Molecular Genetics, University of Rhode Island, Kingston, Rhode Island 02881, USA.
Abstract:
Staphylococcus epidermidis is a major cause of infections associated with indwelling medical devices. Biofilm production is an important virulence attribute in the pathogenesis of device-related infections. Therefore, elimination of these biofilms is an ideal treatment. Salicylate (5 mM) combined with 1 microg of vancomycin per ml inhibited biofilm formation by S. epidermidis (RP62A) by >or=99.9%. When biofilm-coated polystyrene beads were exposed to 5 mM sodium salicylate and 4 microg of vancomycin per ml (one-half the minimum biofilm eradication concentration), there was a >99.9% reduction in viable count.
Insights
Salicylate combined with vancomycin effectively inhibits Staphylococcus epidermidis biofilm formation and reduces existing biofilms. This combination therapy offers a promising strategy for treating device-related infections caused by this common pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Biomaterials Science
Background:
- Staphylococcus epidermidis is a primary cause of infections linked to indwelling medical devices.
- Biofilm formation by S. epidermidis is a critical factor in the pathogenesis of these device-related infections.
- Effective elimination of S. epidermidis biofilms is crucial for successful treatment.
Purpose of the Study:
- To investigate the efficacy of salicylate in combination with vancomycin against Staphylococcus epidermidis biofilms.
- To determine the inhibitory and eradicative effects of this combined treatment on biofilm formation and viability.
Main Methods:
- Assessing biofilm formation inhibition by S. epidermidis (RP62A) using salicylate (5 mM) and vancomycin (1 microg/ml).
- Evaluating the reduction in viable bacterial count on biofilm-coated polystyrene beads treated with sodium salicylate (5 mM) and vancomycin (4 microg/ml).
Main Results:
- The combination of 5 mM salicylate and 1 microg/ml vancomycin inhibited S. epidermidis biofilm formation by over 99.9%.
- Exposure to 5 mM sodium salicylate and 4 microg/ml vancomycin resulted in a greater than 99.9% reduction in viable count on pre-formed biofilms.
Conclusions:
- Salicylate in combination with vancomycin demonstrates potent antibiofilm activity against Staphylococcus epidermidis.
- This synergistic effect suggests a promising therapeutic approach for managing and eradicating S. epidermidis device-related infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Hand hygiene
Hand washing...
Mechanism of Antibiotic Resistance in MRSA
Biofilms
